Abstract
Two long-established and seven newly established endometrial adenocarcinoma cell lines were tested for their capacity to repair sublethal damage after fractionated irradiation. Cell survival was determined with the 96-well plate clonogenic assay based on limiting dilutions. Total radiation doses of 0.75 Gy, 1.25 Gy, 2.50 Gy, 5.00 Gy and 7.50 Gy were used either as a single dose or divided into two or three equal fractions with a 24 h interval. Survival data were fitted to the linear quadratic model, and the area under the survival curve (AUC), equivalent to the mean inactivation dose, was obtained with numerical integration. The amount of sublethal damage repair (SLDR) was expressed as an area-under-the-curve (AUC) ratio comparing survivals from fractionated-dose with those from single-dose experiments. SLDR capacity of the cell lines expressed as an AUC ratio varied between 1.00 and 1.59, and the mean was 1.17. Two highly radiosensitive cell lines were found to be SLDR-deficient, but most of the cell lines studied had some SLDR capacity. We have earlier shown that endometrial cancer cell lines as a group are more radiosensitive than squamous-cell carcinoma (SCC) lines. Data obtained in this study suggest that the capacity for SLDR in these cell lines is rather limited compared with the majority of SCC lines tested. This finding underlines further the high radioresponsiveness of endometrial cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- SLDR:
-
sublethal damage repair
- SCC:
-
squamous-cell carcinoma
- AUC:
-
area under the curve
References
Annual report on the results of treatment in gynecological cancer F.I.G.O. (1991) Int J Gynecol Obstet 36
Begg AC, McNally NJ, Shrieve DC, Kärcher H (1985) A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6:620–626
Bristow RG, Hill RP (1990) Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines II: in vivo radioresponse following fractionated treatment and in vitro/in vivo correlations. Int J Radiat Oncol Biol Phys 18:331–345
Brock RG, Baker FL, Wike JL, Sivon SL, Peters LJ (1990) Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys 18:1283–1286
Elkind MM, Sutton H (1959) Radiation response of mammalian cells grown in culture. I. Repair of X-ray damage in surviving Chinese hamster cells. Radiat Res 25:359–376
Fertil B, Dertinger H, Courdi A, Malaise EP (1984) Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res 99:73–84
Girinsky T, Lubin R, Pignon JP, Chavaudra N, Gazeau J, Dubray B, Cosset JM, Socie G, Fertil B (1992) Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys 25:3–7
Grénman R, Burk D, Virolainen E, Wagner JG, Lichter AS, Carey TE (1988) Radiosensitivity of head and neck cancer cells in vitro. Arch Otolaryngol Head Neck Surg 114:427–431
Grénman R, Burk D, Virolainen E, Buick RN, Church J, Schwartz DR, Carey TE (1989) Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 44:131–136
Grénman R, Carey TE, McClatchey KD, Wagner JG, Pekkola-Heino K, Schwartz DR, Wolf GT, Lacivita LP, Ho L, Baker SR, Krause CJ, Lichter AS (1991) In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67:2741–2747
Grénman, SE, Van Dyke DL, Worsham MJ, Rosario F del, Roberts JA, McClatchey KD, Schwartz DR, Babu VR, Carey TE (1988) UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer. Cancer Res 48:1864–1873
Grénman SE, Worsham MJ, Van Dyke DL, England B, McClatchey KD, Babu VR, Roberts JA, Mäenpää J, Carey TE (1990) Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line. Gynecol Oncol 37:188–199
Hall EJ, Marchese M, Hei TK, Zaider M (1988) Radiation response characteristics of human cells in vitro. Radiat Res 114:415–424
Kelland LR, Steel GG (1989) Recovery of radiation damage in human squamous carcinoma of the cervix. Int J Radiat Biol 55:119–127
Kulmala J, Rantanen V, Pekkola-Heino K, Tuominen J, Grénman R (1994) Dosimetry of irradiation models: the 96-well clonogenic assay for testing radiosensitivity of cell lines. (in press)
Marchese MJ, Zaider M, Hall EJ (1987) Dose-rate effects in normal and malignant cells of human origin. Br J Radiol 60:573–576
Peacock JH, Eady JJ, Edwards S, Holmes A, McMillan TJ, Steel GG (1989) Initial damage or repair as the major determinant of cellular radiosensitivity? Int J Radiat Biol 56:543–547
Pekkola-Heino K, Kulmala J, Klemi P, Lakkala T, Aitasalo K, Joensuu H, Grénman R (1991) Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity. J Cancer Res Clin Oncol 117:597–602
Pekkola-Heino K, Kulmala J, Grénman R (1992) Sublethal damage repair in squamous cell carcinoma cell lines. Head Neck 14:196–199
Rantanen V, Grénman S, Kulmala J, Salmi T, Grénman R (1992) Radiation sensitivity of endometrial carcinoma in vitro. Gynecol Oncol 44:217–222
Rantanen V, Grénman S, Kulmala J, Lakkala T, Sajantila A, Klemi P, Grénman R (1994) Characterization and radiosensitivity of UT-EC-2A and UT-EC-2B, two new highly radiosensitive endometrial cancer cell lines derived from a primary and metastatic tumor of the same patient. (in press)
Richardson GS, Dickersin GR, Atkins L, MacLaughlin DT, Raam S, Merk LP, Bradley FM (1984), KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol Oncol 17:213–230
Rofstad EK, Brustad T (1987) Radioresponsiveness of human melanoma xenografts given fractionated irradiation in vivo—relationship to the initial slope of the cell survival curves in vitro. Radiother Oncol 9:45–56
Thilly WG, DeLuca JG, Furth EE, Hoppe H, IV Kaden DA, Krolenski JJ, Liber HL, Skopek TR, Slapikoff SA, Tizard RJ, Penman BW (1980) Gene locus mutation assays in dipooid human lymphoblast lines. In: Serpes FJ de, Hollaender A (eds) Chemical mutagens, vol 6. Plenum, New York, pp 331–364
Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD (1983) Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In vitro 19:147–158
Weichselbaum RR, Beckett M (1987) The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy. Int J Radiat Oncol Biol Phys 13:709–713
West CML, Davidson SE, Hunter RD (1989) Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int J Radiat Biol 56:761–765
West CML, Davidson SE, Hendry JH, Hunter RD (1991) Prediction of cervical carcinoma response to radiotherapy. Lancet 338:818
Author information
Authors and Affiliations
Additional information
This study was financially supported by the Southwestern Division of the Finnish Cancer Society and the Turku University Foundation
Rights and permissions
About this article
Cite this article
Rantanen, V., Grénman, S., Kulmala, J. et al. Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay. J Cancer Res Clin Oncol 120, 712–716 (1994). https://doi.org/10.1007/BF01194268
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01194268